Urinary morbidity after 125I brachytherapy of the prostate [7]

BJU International

Volumn 93, Issue 6, 2004, Pages 890-

  Henderson, A ^a,b   Bott, S R J ^a   Sooriakumaran, P ^a   Laing, R W ^a   Langley, S E M ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b FRIMLEY PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; RADIOACTIVE IODINE;

BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; HUMAN; LETTER; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE; SYMPTOMATOLOGY; TREATMENT OUTCOME; URGE INCONTINENCE; URINARY TRACT OBSTRUCTION; URINE RETENTION; UROFLOWMETRY; MALE; MICTURITION DISORDER; NOTE; PROSTATE TUMOR; RISK FACTOR;

BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; PROSTATIC NEOPLASMS; RISK FACTORS; URINATION DISORDERS;

EID: 1942509667     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.4737h.x     Document Type: Letter

References (10)

1. Mallick S, Azzouzi R, Cormier L et al. Urinary morbidity after 1251 brachytherapy of the prostate. BJU Int 2003; 92: 555-8
2. Stone NN, Stock RG. Complications following permanent prostate brachytherapy. Eur Urol 2002; 41: 427-33
3. Barry MJ, Williford WO, Chang Y et al. Benign prostatic hyperplasia specific health status measures in clinical research, how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 1995; 154: 1770-4
4. Lee WR, McQuellon RP, McCullough DL. A prospective analysis of patient-reported quality of life after prostate brachytherapy. Semin Urol Oncol 2000; 18: 147-51
5. Lee WR, Hall MC, McQuellon RP et al. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2001; 51: 614-23
6. Wallner K, Roy J, Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal 1-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 1995; 32: 465-71
7. Crook J, McLean M, Catton C et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 2002; 52: 453-60
8. Bucci J, Morris WJ, Keyes M et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002; 53: 91-8
9. Henderson A, Cahill D, Laing RW et al. (125)Iodine prostate brachytherapy. outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics. BJU Int 2002; 90: 567-72
10. Terk MD, Stock RG, Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 1998; 160: 1379-82